Carcinoma, Renal Cell — Study of the Combination of Axitinib Plus Everolimus in Patients With Malignant Advanced Solid Tumors
Citation(s)
Phase I Study of the Combination of Axitinib (AX) Plus Everolimus (EV) in Patients With Malignant Advanced Solid Tumors